Clean Science and Technology Ltd.'s consolidated net profit declined 13% in the fourth quarter of fiscal 2024, but was in line with analysts' estimates.
The company posted a profit of Rs 70 crore in the quarter-ended March, in comparison with Rs 81 crore in the year-ago period, according to an exchange filing on Wednesday. Analysts tracked by Bloomberg had estimated a profit of Rs 67.34 crore.
Clean Science And Technology Q4 FY24 (Consolidated, YoY)
Revenue up 5% to Rs 228 crore versus Rs 217 crore (Bloomberg Estimate: Rs 212.40 crore).
Ebitda down 10% to Rs 94 crore versus Rs 105 crore (Bloomberg Estimate: Rs 91.59 crore).
Margin at 41.5% versus 48.4% (Bloomberg Estimate: 43.10%).
Net profit down 13% to Rs 70 crore versus Rs 81 crore (Bloomberg Estimate: Rs 67.34 crore).
Key Highlights
Revenue Profile FY24
Contribution from newer products increased.
Performance segment profile diversified, with addition of new products (HALS 770 and 701). However, realisation impacted growth.
Pharma and agro segment saw fall in growth, primarily Guaiacol-led, which recovered in second half. DCC contributed positively to growth.
FMCG segment also contributed positively to growth, which was volume-led.
Domestic market share improvement was led by new products.
Revenue share of Americas and Europe remained steady.
China's share improved during H2 FY24.
Incurred total capex of ~ Rs 235 crore during FY24, including investment in subsidiary of Rs 215 crore.
Clean Fino-Chem Ltd. commercialised during March 2024.
Shares of the company were trading 2.25% higher at Rs 1,318 apiece on the NSE at 2:26 pm, as compared with a 0.07% decline in the benchmark Nifty 50.